Moderna provides an update on regulatory submissions for RSV vaccine candidate, mRNA-1345

FHS
July 10, 2023
6:23 am

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.

Future Surgery returns as the flagship event for the surgical sector – Lifescience Industry News

Over 4,500 healthcare professionals from across the surgical sector will reunite in London on 15–16 November 2022 for the largest surgical event of the year.

October 28, 2022

Neural circuitry in the spinal cord allows brain-independent motor learning

Aya Takeoka at the RIKEN Center for Brain Science (CBS) in Japan and colleagues have discovered the neural circuitry in the spinal cord that allows

April 13, 2024

Integrating HIPAA Compliance Into Digital Communication

Healthcare organizations have been increasingly adopting digital communication channels like email and text messaging. These channels offer convenience and flexibility for both healthcare providers and

June 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.